This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Susan Desmond-Hellmann Joins Facebook Board Of Directors

MENLO PARK, Calif., March 6, 2013 /PRNewswire/ -- Facebook announced today that Susan Desmond-Hellmann, M.D., M.P.H., chancellor of the University of California, San Francisco (UCSF), has been elected to the company's board of directors.

"Sue has a great track record of building and managing a diverse set of organizations, so her insights will be valuable as we continue to expand into new areas," said Mark Zuckerberg, founder and CEO of Facebook.  "Her experience shaping public policy and operating public companies fits well with the rest of the board and will make us an even stronger company."

"I've always been drawn to organizations that do ground-breaking work," said Desmond-Hellmann.  "Facebook has an ambitious mission and long-term vision of innovation that is transforming how people connect with one another.  I'm proud to be part of a company that is serving such an important purpose in the world."

As UCSF Chancellor, Desmond-Hellmann oversees all aspects of the university and medical center's strategy and operations.  She previously served as president, product development at the biotechnology pioneer, Genentech.  In this role, she was responsible for Genentech's pre-clinical and clinical development, process research and development, business development and product portfolio management. During her 14 years with the company, Desmond-Hellmann brought numerous cutting-edge cancer medicines to market to help people battle the disease.

Desmond-Hellmann completed her clinical training at UCSF and is board-certified in internal medicine and medical oncology.  During her training at UCSF, she spent two years as a visiting faculty member at the Uganda Cancer Institute, studying HIV/AIDS and cancer.  She also holds a master's degree in public health from the University of California, Berkeley.

Desmond-Hellmann is on the board of directors for Procter & Gamble, and she also serves as a trustee for the Howard Hughes Medical Institute, a nonprofit media research organization.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,689.86 -56.12 -0.32%
S&P 500 2,103.84 -4.79 -0.23%
NASDAQ 5,128.2810 -0.5040 -0.01%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs